Pharmacokinetic interaction between chemotherapy for non-Hodgkin's lymphoma and protease inhibitors in HIV-1-infected patients | Zendy

Mario Cruciani | Zendy; Giorgio Gatti | Zendy; Emanuela Vaccher | Zendy; Giampiero di Gennaro | Zendy; Roberta Cinelli | Zendy; Matteo Bassetti | Zendy; Umberto Tirelli | Zendy; Dante Bassetti | Zendy

Open Access

Pharmacokinetic interaction between chemotherapy for non-Hodgkin's lymphoma and protease inhibitors in HIV-1-infected patients

Author(s) -

Mario Cruciani,

Giorgio Gatti,

Emanuela Vaccher,

Giampiero di Gennaro,

Roberta Cinelli,

Matteo Bassetti,

Umberto Tirelli,

Dante Bassetti

Publication year - 2005

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dki050

Subject(s) - indinavir , nelfinavir , medicine , chop , vincristine , chemotherapy , pharmacokinetics , pharmacology , lymphoma , crossover study , gastroenterology , cyclophosphamide , oncology , viral load , sida , immunology , placebo , human immunodeficiency virus (hiv) , viral disease , antiretroviral therapy , pathology , alternative medicine

We have investigated whether chemotherapy for HIV-related systemic non-Hodgkin's lymphoma (NHL) affects the pharmacokinetics of protease inhibitors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research